Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of <sup>18</sup>F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy.

Actas urologicas espanolas·2020
Same author

Hybrid image (SPECT/CT) in the evaluation and management of a patient with heterotopic calcification and hip prostheses.

Revista espanola de medicina nuclear e imagen molecular·2019
Same author

Uvular squamous cell carcinoma concomitant with oesophageal carcinoma in a <sup>18</sup>F-FDG PET/CT study.

Revista espanola de medicina nuclear e imagen molecular·2019
Same author

Health-related quality of life in caregivers of patients with Alzheimer's disease.

Neurologia (Barcelona, Spain)·2016
Same author

A rare case of double parathyroid adenoma evidenced by <sup>99m</sup>Tc-sestaMIBI SPECT/CT.

Revista espanola de medicina nuclear e imagen molecular·2016
Same author

[Aspiration pneumonia diagnosed by esophageal transit SPECT/CT scintigraphy].

Revista espanola de medicina nuclear e imagen molecular·2014

Related Experiment Video

Updated: May 6, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K

Longitudinal evaluation using FP-CIT in patients with parkinsonism.

M D Martínez-Valle Torres1, S J Ortega Lozano2, M J Gómez Heredia3

  • 1Servicio de Medicina Nuclear, Hospital Universitario «Virgen de la Victoria», Málaga, España.

Neurologia (Barcelona, Spain)
|October 22, 2013
PubMed
Summary

Serial FP-CIT scans for parkinsonism are usually not needed, though they may be justified in specific clinical scenarios, particularly when initial results are negative but symptoms progress.

Keywords:
Dopamine transportersFalse negativesFalsos negativosI123-IoflupaneI123-IoflupanoParkinsonismParkinsonismoTransportadores de dopamina

More Related Videos

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

7.9K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K

Related Experiment Videos

Last Updated: May 6, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.4K
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

7.9K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.7K

Area of Science:

  • Neurology
  • Nuclear Medicine

Background:

  • Parkinsonism diagnosis can be challenging, with initial imaging sometimes yielding inconclusive results.
  • DaTscans (FP-CIT) are used to assess dopaminergic deficits in parkinsonian syndromes.

Purpose of the Study:

  • To evaluate the utility of serial FP-CIT (DaTscans) in patients with parkinsonism, focusing on cases with initially negative findings.
  • To analyze discrepancies between initial FP-CIT results and clinical progression.

Main Methods:

  • Retrospective analysis of 92 parkinsonism patients who underwent two FP-CIT studies.
  • Semi-quantitative analysis of clinical history and literature to interpret discrepant results.

Main Results:

  • Eleven of 92 patients showed discrepancies between initial and follow-up FP-CIT studies.
  • Seven patients initially had normal FP-CIT scans but later showed pathological findings.
  • Tremor-dominant parkinsonism was noted in 4 of these 7 cases.

Conclusions:

  • Serial FP-CIT (DaTscans) are generally not required for parkinsonism diagnosis.
  • Repeat FP-CIT imaging may be beneficial in select clinical situations with evolving symptoms or initial uncertainty.